{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"0.036","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"5,588,571,777","primaryexch":"HKEX","ric":"1312.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"M","am_u":"K","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BD0F7B5","am":"189.32","iv":"","ew_strike":"","as":"0.033","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"0.032","registrar":"Tricor Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"6,000","update_time":"2025-09-26 10:38:37.0","lo52":"0.020","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Wang Feifei","underlying_ric":"1312.HK","hi52":"0.048","issuer_name":"Kontafarma China Holdings Ltd.","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 15:58","aum_date":"","lo":"0.032","mkt_cap":"184.42","f_aum_hkd":null,"ew_sub_per_to":"","ls":"0.033","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-0.001","aum":"","issued_shares_class_B":null,"vo":"5.68","secondary_listing_flag":false,"listing_date":"18 Jan 2012","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Kontafarma China Holdings Ltd.","nm_s":"KONTA CHINA","sym":"1312","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.001","strike_price":"","summary":"Kontafarma China Holdings Ltd, formely Tongfang Kontafarma Holdings Ltd, is an investment holding company principally engaged in pharmaceutical business. The Company operates its business through two business segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of prescription drugs, including chemical drugs and prescribed traditional Chinese medicines, and laboratory related products. The Fitness Business is segment is engaged in the operation of fitness centers, the provision of consultation services for fitness and health activities, as well as the operation of the franchise business for royalty fee income.","op":"0.033","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Rooms 12A15-12A20, 12A/F<br/>Sun Hung Kai Centre<br/>30 Harbour Road<br/>Wanchai, Hong Kong","pc":"-2.94","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"HKD","hdr":false,"launch_date":"","hc":"0.034","isin":"KYG8918D1088","moneyness":""}},"qid":"1758890885133"}
